<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1505840</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lagu&#xed;a</surname>
<given-names>Fernando</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1070269"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chojnacki</surname>
<given-names>Jakub</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erkizia</surname>
<given-names>Itziar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/715562"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geli</surname>
<given-names>Mar&#xed;a Isabel</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Enrich</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/498330"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Martinez-Picado</surname>
<given-names>Javier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/661502"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Resa-Infante</surname>
<given-names>Patricia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2859468"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>IrsiCaixa</institution>, <addr-line>Badalona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>CIBERINFEC</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Germans Trias i Pujol Research Institute (IGTP)</institution>, <addr-line>Badalona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Cell Biology, Institute for Molecular Biology of Barcelona (IBMB, CSIC)</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Cell Compartments and Signaling Group, Institut d&#x2019;Investigacions Biomediques August Pi i Sunyer (IDIBAPS)</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Departament de Biomedicina, Facultat de Medicina i Ci&#xe8;ncies de la Salut, Universitat de Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>University of Vic-Central University of Catalonia (UVic-UCC)</institution>, <addr-line>Vic</addr-line>, <country>Spain</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Catalan Institution for Research and Advanced Studies (ICREA)</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Laura Fantuzzi, National Institute of Health (ISS), Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Guido Poli, Vita-Salute San Raffaele University, Italy</p>
<p>Andrew Nicholas Harman, The University of Sydney, Australia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Patricia Resa-Infante, <email xlink:href="mailto:prinfante@irsicaixa.es">prinfante@irsicaixa.es</email>; Javier Martinez-Picado, <email xlink:href="mailto:jmpicado@irsicaixa.es">jmpicado@irsicaixa.es</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1505840</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Lagu&#xed;a, Chojnacki, Erkizia, Geli, Enrich, Martinez-Picado and Resa-Infante</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Lagu&#xed;a, Chojnacki, Erkizia, Geli, Enrich, Martinez-Picado and Resa-Infante</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>HIV-1 exploits dendritic cells (DCs) to spread throughout the body via specific recognition of gangliosides present on the viral envelope by the CD169/Siglec-1 membrane receptor. This interaction triggers the internalization of HIV-1 within a structure known as the sac-like compartment. While the mechanism underlying sac-like compartment formation remains elusive, prior research indicates that the process is clathrin-independent and cell membrane cholesterol&#x2013;dependent and involves transient disruption of cortical actin. Here, we investigate the potential involvement of massive endocytosis (MEND) in this process.</p>
</sec>
<sec>
<title>Methods</title>
<p>We used live cell confocal imaging to measure the dimensions and dynamics of the compartment. We assessed the role of actin and cholesterol in fixed and live cells using confocal microscopy and evaluated the effect of PI3K and protein palmytoilation inhibitors during viral uptake.</p>
</sec>
<sec>
<title>Results</title>
<p>Our data demonstrate extensive plasma membrane invagination based on sac-like compartment dimensions (2.9 &#x3bc;m in diameter and 20 &#x3bc;m<sup>3</sup> in volume). We showed that the cholesterol concentration doubles within the regions of viral uptake, suggesting lipid-phase separation, and that development of the sac-like compartment is accompanied by transient depolarization of cortical actin. Moreover, we observed that protein palmitoylation and PI3K inhibition reduce the sac-like compartment formation rate from 70% to 20% and 40%, respectively.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Our results indicate the involvement of MEND mechanisms during sac-like compartment formation.</p>
</sec>
</abstract>
<kwd-group>
<kwd>dendritic cells</kwd>
<kwd>CD169/Siglec1</kwd>
<kwd>HIV</kwd>
<kwd>sac-like compartment</kwd>
<kwd>MEND</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="53"/>
<page-count count="15"/>
<word-count count="7278"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Viral Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Antigen-presenting cells of the myeloid lineage, including monocytes, macrophages, and dendritic cells (DCs), initiate immune responses and are crucial for inducing resistance to invading viruses. DCs patrol peripheral tissues and are among the first cells to interact with incoming viruses, enabling capture, processing, and antigen presentation. However, some viruses, such as the human immunodeficiency virus (HIV-1), take advantage of myeloid cell activity to facilitate viral dissemination in a <italic>trans</italic>-infection process. Thus, captured viral particles are transferred to target CD4<sup>+</sup> T cells located in secondary lymphoid tissue, with no productive infection in the myeloid cell (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>The sialic acid&#x2013;binding Ig-like lectin 1 (Siglec-1/CD169) transmembrane protein is a cell adhesion molecule that mediates HIV-1 uptake in DCs and macrophages. This myeloid receptor is expressed in an inflammation-dependent manner following activation with type-I interferon and recognizes sialic acid molecules in gangliosides such as GM-1 and GM-3, which are incorporated into the envelope of HIV particles as they bud from the plasma membrane of infected cells (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). Upon binding of HIV-1 particles to CD169, the receptor polarizes towards a cellular pole and traps the viral particles within a sac-like compartment (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). In this structure, viral particles are partially protected from degradation and remain connected to the extracellular space facilitating <italic>trans</italic>-infection (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). This phenomenon has been demonstrated in several cellular models, including mature monocyte-derived dendritic cells (MDDCs), mature monocyte-derived macrophages (MDMs), and CD169<sup>+</sup> CD11c<sup>+</sup> BDCA1<sup>+</sup> <italic>ex-vivo</italic> cells from tonsils (<xref ref-type="bibr" rid="B15">15</xref>). In myeloid cells obtained <italic>ex-vivo</italic> from dermal tissues, CD169-dependent binding to HIV-1 and <italic>trans</italic>-infection of CD4<sup>+</sup> T cells have been observed, particularly in MDMs, but also partially in MDDCs (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Moreover, sac-like compartments have been detected <italic>in vivo</italic> in DCs from infected vaginal tissue (<xref ref-type="bibr" rid="B2">2</xref>). These compartments display similarities to the virus-containing compartments (VCCs) described in macrophages, which are also formed upon interaction between CD169 and HIV-1 and accumulate <italic>de novo</italic> synthesized viral particles (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>While viruses can utilize different endocytosis mechanisms for replicating in the host cell (<xref ref-type="bibr" rid="B21">21</xref>), CD169-dependent viral entry does not lead to productive infection (<xref ref-type="bibr" rid="B6">6</xref>). Information on the initiation of endocytic cascade by this receptor has been limited, particularly considering the absence of a tyrosine-based activation motif in the CD169 cytosolic domain (<xref ref-type="bibr" rid="B22">22</xref>). Viral particles bind to the cell membrane of MDDCs and coalesce on the cell surface before being internalized and accumulating in the sac-like compartment. Similarly, the mechanism behind viral particle migration and sac-like compartment formation remains unclear. While cholesterol sequestration and cytoskeleton disruption both prevent accumulation of HIV-1 in the sac-like compartment (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B23">23</xref>), the mechanism triggering these processes is not well understood. Filamentous actin regulators, such as ERM complex and formin, need to be inactivated immediately after viral binding to enable CD169 nanoclustering and virus polarization in the cell membrane at very early stages of sac-like compartment formation, indicating the requirement of major cortical actin rearrangement during sac-like compartment formation (<xref ref-type="bibr" rid="B23">23</xref>). In turn, inhibition of clathrin-mediated endocytosis does not affect the process (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B24">24</xref>). The conclusions reached above suggest that an unknown specific signaling event may trigger actin-independent sac-like compartment formation using unconventional mechanisms of the cellular endocytic machinery for this kind of virus internalization.</p>
<p>Massive endocytosis (MEND) constitutes a recently identified endocytosis mechanism that promotes the internalization of large portions of plasma membrane (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). MEND is an unconventional clathrin- and dynamin-independent process whose main driving force is the coalescence of liquid-ordered membrane domains containing cholesterol and other lipids. The main characteristics of MEND are as follows: (i) it requires palmitoylation of membrane proteins (<xref ref-type="bibr" rid="B27">27</xref>&#x2013;<xref ref-type="bibr" rid="B29">29</xref>); (ii) it can be regulated by Ca<sup>2+</sup> activation (<xref ref-type="bibr" rid="B30">30</xref>); and (iii) it requires the presence of the lipid molecule phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P<sub>2</sub>), which is phosphorylated by class I phosphoinositide 3-OH kinase (PI3K) (<xref ref-type="bibr" rid="B31">31</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>). MEND preferentially takes place in actin-free zones and is associated with lipid-phase separation (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>Building upon previous studies that investigated viral internalization into DCs, we hypothesized that MEND could be responsible for sac-like compartment formation following viral binding to CD169. In this study, we provide evidence demonstrating that sac-like compartment formation involves extensive internalization of viral particles firmly adhered to the cell membrane that is dependent on PI3K activity and protein palmitoylation. Furthermore, we showed that cortical actin fibers transiently disappear during early stages of sac-like compartment formation. In contrast, cholesterol coalesces with the polarized virus prior to internalization and sac-like compartment formation, suggesting lipid-phase separation. In conclusion, we propose that HIV-1 exploits MEND to facilitate its internalization into DCs after binding to CD169.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Ethics and biosafety statements</title>
<p>The study was approved by the institutional review board for biomedical research of Hospital Germans Trias i Pujol (HUGTiP). The participants provided written informed consent to participate in this study.</p>
</sec>
<sec id="s2_2">
<title>Primary myeloid cellular model</title>
<p>Peripheral blood mononuclear cells (PBMCs) from HIV-seronegative donors were obtained using Ficoll-Hypaque gradient centrifugation. The monocyte population (&gt;97% CD14<sup>+</sup>) was isolated using CD14-positive magnetic bead&#x2013;based selection (cat. no. 130-050-201, Miltenyi Biotec). Cells were maintained at 37&#xb0;C and 5% CO<sub>2</sub> in RPMI medium (cat. no. 11875168, Gibco) supplemented with 10% FBS (cat. no. A5256701, Life Technologies), penicillin/streptomycin at 100 IU/ml (cat. no. 15070-022, Life Technologies), and of granulocyte-macrophage colony-stimulating factor and interleukin-4 at 1000 IU/ml (cat. no. 215-GM-500 and 204-IL-500, R&amp;D) for seven days with replacement of media and cytokines every two days. Activated MDDCs were differentiated by culturing immature MDDCs at day five for a further two days in the presence of 100 ng/ml lipopolysaccharide (LPS, cat.no. L4391-1MG, Sigma-Aldrich) to obtain matured MDDCs.</p>
</sec>
<sec id="s2_3">
<title>Generation of viral particles (VLP<sub>HIV</sub>)</title>
<p>HEK-293T/17 cells (cat. no. CRL-11268, ATCC repository) were maintained in DMEM (cat.no. 11995073, Gibco) supplemented with 10% FBS and penicillin/streptomycin at 100 IU/ml at 37&#xb0;C with 8% CO<sub>2</sub>. VLP<sub>HIV</sub> stocks were generated by transfecting 1E7 HEK-293T/17 cells with 15 &#xb5;g of pHIV-Gag-eGFP plasmid (cat. no. 11468, NIH AIDS Reagent Program) using 15 &#xb5;l of LipoD293 (Ver. II) reagent (cat. no. SL100668, SignaGen). After 2 days, supernatants containing VLP<sub>HIV</sub> were centrifuged for 5 min at 400 xg, filtered (Millex HV, 0.45 &#x3bc;m; Millipore) and frozen at &#x2212;80&#xb0;C until use.</p>
</sec>
<sec id="s2_4">
<title>Live cell imaging by confocal microscopy</title>
<p>MDDCs were centrifuged, washed with PBS and stained with CellTracker&#x2122; Red CMTPX Dye (cat. no. C34552, ThermoFisher). 5E5 cells diluted in 1 ml RPMI were transferred to 35-mm wells for culture imaging (cat. no. 81156, Ibidi) pretreated with poly-L-lysine 20 &#xb5;g/ml (cat. no. P4832, Sigma-Aldrich). Cells were pulsed with saturating levels of VLP<sub>HIV</sub> on ice for 15 min, before being washed with PBS and placed into a microscope stage incubator at 37&#xb0;C and 5% CO<sub>2</sub>. Images were acquired using an Andor Dragonfly 505 spinning disk confocal microscope equipped with an apochromatic 100X/1.49 oil objective and a Sona 4.2 B11 sCMOS camera controlled with Fusion Software. Z-scan mode was set at a 0.2-&#xb5;m XY pixel size to image the whole cell volume. Laser power was set at a minimum of 0.5% to avoid phototoxicity. Images were acquired every 2 min for 90 min. Eight fields were selected in multiposition mode to maximize the number of imaged cells.</p>
<p>To measure cholesterol coalescence, 5E5 MDDCs were stained for 5 min at room temperature with two lipid probes, either 75 nM of cholesterol-PEG(1k)-Abberior STAR RED dye (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>) or 28 nM of DPPE-Abberior STAR RED dye (cat. no. STRED-0200-1MG, Abberior GmbH). Cholesterol-PEG (1 k)-Abberior STAR RED was a gift from Prof. Christian Eggeling (Friedrich Schiller University Jena &amp; Leibniz Institute of Photonic Technology, Jena, Germany). The probe was synthesized by fluorescent labelling of cholesterol-PEG(1000)-NH2 (PG2-AMCS, Nanocs Inc., NY, USA) with the amine reactive dye Abberior STAR RED-NHS (STRED-0002-1MG, Abberior GmbH). Cells were then washed, pulsed with VLP<sub>HIV</sub>, and transferred to multiwell plates (cat. no. 81156, Ibidi) for live imaging as described above.</p>
</sec>
<sec id="s2_5">
<title>Inhibitory treatment of MDDCs and fixation</title>
<p>MDDCs stained with CellTracker&#x2122; Red CMTPX dye were treated for 2 h at 37&#xb0;C with 100 nM wortmannin PI3K inhibitor (cat. no. PHZ1301, ThermoFisher), 25 &#xb5;M 2-bromopalmitate palmitoyl-acyl transferase inhibitor (2-BP; cat. no. 238422, Merck), or 100 &#xb5;M 5-(N-Ethyl-N-isopropyl) of the specific macropinocytosis inhibitor 5-(N-ethyl-N-isopropyl) amiloride (EIPA; cat. no. A3085, Merck). Then, MDDCs were pulsed with saturating levels of VLP<sub>HIV</sub> for 15 min on ice, washed with PBS, resuspended in 1 ml RPMI, and incubated for 6 h at 37&#xb0;C and 5% CO<sub>2</sub>. In parallel, treated cells were incubated with either labelled transferrin at 25 &#xb5;g/&#xb5;L (Tfn-Alexa Fluor 488; cat. no. T23366, ThermoFisher) for 30 min or with labelled recombinant cholera toxin subunit B at 1 &#xb5;g/&#xb5;l (Ctx&#x3b2;-Alexa Fluor 488; cat. no. C34775, ThermoFisher) for 1 h. After the indicated incubation time, MDDCs were transferred to glass coverslips coated with poly-L-lysine solution (cat. no. P8920, Merck) and fixed in PFA 4% for 20 min (cat. no. P6148, Merck). PFA was then replaced with PBS-0.5% BSA w/v (cat. no. A966-506, Sigma-Aldrich) and stored at 4&#xb0;C.</p>
</sec>
<sec id="s2_6">
<title>Intracellular staining of fixed cells</title>
<p>MDDCs were treated for 1 h with permeabilization buffer (5 mg/ml BSA (cat. no. A7906 Merck) and 1 mg/ml saponin (cat. No. SAE0073, Merck). Subsequently, cells were incubated for 1 h with 20 ng/ml of anti-CD169 antibody clone #6H9 (<xref ref-type="bibr" rid="B7">7</xref>) and NHS conjugated with Abberior STAR RED-NHS dye (STRED-0002-1MG, Abberior GmbH). When indicated, actin fibers were stained for 1 h with 165 nM Phalloidin-Alexa Fluor 555 (cat. no. A30106, ThermoFisher) after treatment with permeabilization buffer. Nuclei were stained with 300 nM DAPI solution in PBS (cat. no. D1306, ThermoFisher) for 5 min and then washed with PBS. Coverslips were mounted onto glass slides with ProLong Glass Antifade mounting media (cat. no. P36982, ThermoFisher) and sealed with nail polish. Fixed samples were then imaged using Andor Dragonfly 505 spinning disk confocal microscope.</p>
</sec>
<sec id="s2_7">
<title>Image analysis and quantification</title>
<p>Sac-like compartment diameter was measured by tracing a line with the line tool in Fiji/ImageJ software over the sac-like compartment in a projection of 3 XY slices comprising the sac-like compartment. To determine sac-like compartment volume, we applied the &#x201c;Volume Calculator&#x201d; tool in Fiji/ImageJ software using the eGFP channel signal corresponding to VLP<sub>HIV</sub> in the sac-like compartment. 3D reconstruction was performed with the plugin &#x201c;3D viewer&#x201d; in Fiji/ImageJ software. Orthogonal views in the Z axis were obtained by tracing a line in the XY plane across the cell and applying the Reslice-Z tool in Fiji/ImageJ software.</p>
<p>To distinguish VLP<sub>HIV</sub> distribution, we utilized a script based on the circularity of the eGFP channel. To systematize the analysis, we applied the &#x201c;Subtract Background&#x201d; and &#x201c;Convert to Mask&#x201d; commands to generate a script based on tools from Fiji/ImageJ software, which uses the cell tracker channel to determine the regions of interest (ROI) corresponding to cell boundaries. We set a minimum sac-like compartment size of 1 micron; therefore, cells with no particles were assigned to random binding. We used circularity in &#x201c;Analyze Particles&#x201d; to determine whether cells were polarizing VLP<sub>HIV</sub> (circularity value = 0 - 0.7) or whether cells formed sac-like compartment (circularity value = 0.7 - 1). Analysis of internalization of Tfn and Ctx&#x3b2; was based on the cell tracker channel. This was used to determine the ROI and analyze the mean fluorescence intensity of the green channel, which corresponds to these cargoes, inside ROIs. Image analysis scripts are provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>.</p>
<p>We analyzed cholesterol coalescence by determining an ROI corresponding to the membrane area where VLP<sub>HIV</sub> coalesces to measure the mean fluorescence intensity (MFI) of the lipid probe in the VLP<sub>HIV</sub> ROI. In parallel, we determined the whole membrane ROI manually to measure the MFI of the lipid probe in the whole membrane. A ratio between the two MFI measured for each ROI was calculated as an indicator of the fold change in the cholesterol probe concentration.</p>
<p>We performed a pixel-by-pixel colocalization test to compare colocalization in VLP<sub>HIV</sub> and CD169. This enabled us to calculate the Pearson correlation coefficient for both fluorescence signals. The Pearson correlation coefficient ranges from -1 to +1, with higher values indicating a better correlation.</p>
</sec>
<sec id="s2_8">
<title>Statistical analysis</title>
<p>All the statistical tests were performed with GraphPad software. In the analysis of sac-like compartment size and volume, 25 cells from two different donors were measured. The results are represented using a violin plot graph, indicating median and quartiles. Average and standard deviation were calculated for volume and maximal axial size.</p>
<p>To analyze cholesterol coalescence, 78 cells from three different blood donors were measured. The results are represented using a violin plot graph, indicating median and quartiles. A paired t test was used to analyze the statistical significance of the increases in the cholesterol probe in the VLP<sub>HIV</sub> coalescence regions of the cell membrane.</p>
<p>In the experiments with 2-BP, wortmannin, and EIPA inhibitory treatments, groups of at least 100 cells for each condition were counted and analyzed. MDDCs were isolated from 9, 7, and 4 blood donors, respectively. The Wilcoxon test was used to analyze the statistical significance of the changes in the phenotype distribution described for sac-like compartment formation. In control experiments to measure endocytosis of Tfn and Ctx&#x3b2; upon treatment with 2-BP and wortmannin, groups of at least 100 cells for each condition were counted and analyzed. MDDCs were isolated from seven blood donors. The results are represented using a violin plot graph, indicating median and quartiles. The Wilcoxon test was performed in GraphPad to analyze the statistical significance of changes in the proportion of cells internalizing the cargoes.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>The dynamics of sac-like compartment formation do not match conventional endocytosis mechanisms</title>
<p>Every endocytosis mechanism produces transport intermediates with distinct sizes and morphologies. To investigate which endocytosis mechanism drives sac-like compartment formation, we measured the size, volume, and temporal dynamics of sac-like compartments in activated MDDCs. MDDCs were pulsed with HIV-1 virus-like particles expressing recombinant Gag-eGFP protein (VLP<sub>HIV</sub>) and imaged using confocal microscopy. MDDCs incubated in a culture chamber and imaged <italic>in vivo</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) showed behavior similar to that of MDDCs pulsed with VLP<sub>HIV</sub> and then fixed (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>), thus validating live cell imaging to study sac-like compartment formation. While the sac-like compartment is not perfectly spherical, we determined that the average of two donors of maximal axial size of the sac-like compartments was 2.9 &#xb1; 0.7 &#x3bc;m (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>), and the volume, measured after 3D reconstruction, was found to be 20.0 &#xb1; 9.9 &#x3bc;m<sup>3</sup> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). These findings provide significant insight into the morphology and dimensions of sac-like compartments in MDDCs exposed to VLP<sub>HIV</sub>, shedding light on the intracellular dynamics of viral uptake and compartmentalization within DCs.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Measurement of sac-like compartment dimensions and dynamics reveals that its formation does not match conventional endocytosis pathways. MDDCs were pulsed with VLP<sub>HIV</sub> (green channel) and imaged <italic>in vivo</italic> by live microscopy to study sac-like compartment formation and measure its size and volume. Cell volume was determined with a cell tracer fluorescent probe (red channel). <bold>(A)</bold> Confocal immunofluorescence of fixed MDDCs pulsed with VLP<sub>HIV</sub> (green channel) and stained with anti-CD169 antibody (magenta channel) and a cell tracer (red channel). <bold>(B)</bold> Confocal live microscopy image of MDDCs pulsed with VLP<sub>HIV</sub> (green channel) and stained with cell tracer (red channel). <bold>(C)</bold> Maximal axial size quantification of the sac-like compartment in 25 MDDCs from two donors. Schematic XY plane acquisition in an MDDC is presented to illustrate the maximal axial size of the sac-like compartment used. Median and quartile are shown in the graph. <bold>(D)</bold> Volume quantification of sac-like compartment s in 25 MDDCs from two donors (same cells as used in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Schematic view of Z-stack acquisition of multiple proximal XY planes in an MDDC is presented to illustrate the 3D images used to calculate sac-like compartment volume. Median and quartile are shown in the graph. <bold>(E)</bold> Sac-like compartment dynamics by live cell confocal microscopy. Images were acquired every 2&#xa0;min for 70&#xa0;min, and representative time points during viral polarization are shown. The top row represents projections of Z-axis slices (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Video S1</bold>
</xref>). The bottom row represents 3D reconstruction of the same representative cell (<xref
ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Video S2</bold>
</xref>). A total of 25 MDDCs forming sac-like compartment structures were partially or totally
recorded to evaluate the process. Schematic figures have been created with <uri
xlink:href="https://BioRender">BioRender</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1505840-g001.tif"/>
</fig>
<p>We conducted live-cell confocal microscopy imaging to determine whether VLP<sub>HIV</sub> internalize simultaneously or accumulate after trespassing cell boundaries. Our observations from 3D reconstruction and Z-Slice projection of the corresponding microscope images revealed that bound VLP<sub>HIV</sub> remained localized on the outer membrane surface until polarization in a distinct region within a timeframe of less than 5 min. Then, they internalized to form a single compartment, where all VLP<sub>HIV</sub> were densely packed together (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Videos S1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM2">
<bold>S2</bold>
</xref>).</p>
<p>The formation of this unique compartment involves extensive internalization of VLP<sub>HIV</sub> attached to the cellular membrane into a compartment in the cytoplasm. This dynamic imaging approach provides valuable insights into the temporal and spatial dynamics underlying internalization of VLP<sub>HIV</sub>, shedding light on the mechanisms of viral entry and compartmentalization within the cell.</p>
</sec>
<sec id="s3_2">
<title>Actin cytoskeleton rearrangement participates in the biogenesis and maintenance of the sac-like compartment in MDDCs</title>
<p>To investigate the involvement of actin in sac-like compartment biogenesis, we pulsed MDDCs with VLP<sub>HIV</sub> at different time points, fixed them, and stained actin fibers using phalloidin-AF555. This enabled us to measure changes in actin distribution and identify potential intermediate phenotypes during the sac-like compartment formation process. Based on the distribution of VLP<sub>HIV</sub> and in the presence or absence of actin, we categorized five different phenotypes (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). We observed that actin fibers in MDDCs were concentrated within dendrites and that the actin cortex localized beneath the plasma membrane, as compared to the rest of the cytoplasm. Polarization of VLP<sub>HIV</sub> was observed in some cells, with actin fibers present in membrane-associated regions, whereas in other cells, the actin cortex was absent in regions displaying polarized VLP<sub>HIV</sub> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Some cells with internalized VLP<sub>HIV</sub> did not exhibit colocalization with actin, whereas others displayed fully formed sac-like compartment that colocalized with actin fibers (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The actin cytoskeleton is essential to maintain sac-like compartment but is absent at late stages
of polarization and sac-like compartment formation. MDDCs were pulsed with VLP<sub>HIV</sub> (green
channel) and fixed at different time points. MDDCs were stained with phalloidin-AF568 (red channel)
to detect actin fibers and study their distribution during sac-like compartment formation. Cell
nuclei were stained with DAPI (blue channel). <bold>(A)</bold> The MDDC phenotype was determined by
random binding, polarization, and internalization of VLP<sub>HIV</sub>, as well as their potential
colocalization with actin fibers. Created with <uri xlink:href="https://BioRender.com">BioRender.com</uri>. <bold>(B)</bold> Representative images of the distribution phenotype of MDDCs pulsed for 2&#xa0;h with polarized VLP<sub>HIV</sub>. One XY slice per cell is shown. <bold>(C)</bold> Representative images of MDDCs pulsed for 2&#xa0;h, with internalized VLP<sub>HIV</sub> forming the sac-like compartment. Only one XY slice per cell is shown. <bold>(D)</bold> Dynamic analysis of VLP<sub>HIV</sub> distribution in MDDCs from two donors classified as indicated in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>. Cells were pulsed with VLP<sub>HIV</sub> and fixed at different time points (1&#xa0;h, 2&#xa0;h, 6&#xa0;h, and 16&#xa0;h). At least 100 cells were evaluated at each time point. The graph shows percentage values above 10% for each phenotype. <bold>(E)</bold> Confocal microscopy including orthogonal view of fixed MDDCs pulsed for 2&#xa0;h with VLP<sub>HIV</sub> and additionally stained with anti-CD169 Ab (magenta channel). The side pictures show the YZ axis slice; lower pictures show the XZ axis slice. The yellow arrow indicates the sac-like compartment.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1505840-g002.tif"/>
</fig>
<p>When we quantified the dynamic incorporation of VLP<sub>HIV</sub> and its colocalization with actin fibers in MDDCs from different donors, we observed that VLP<sub>HIV</sub> polarized in a single pole phenotype is more abundant than a sac-like compartment fully formed by internalized VLP<sub>HIV</sub> at early time points (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<p>The proportion of cells with VLP<sub>HIV</sub> internalized in sac-like compartments colocalizing with actin increased from 10% at earlier time points to over 50% of total evaluated cells after 16 h of incubation. This suggests that actin colocalization represents the final stage in the sac-like compartment formation process. Concurrently, the polarized phenotype colocalizing with actin decreased from approximately 50% to less than 20% of total evaluated cells. Interestingly, phenotypes where actin does not colocalize with VLP<sub>HIV</sub> were more frequent at intermediate time points, suggesting they are transient states during sac-like compartment formation. Moreover, the orthogonal view of sac-like compartments lacking actin colocalization revealed discontinuities in the actin cortex, forming channel-like structures (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Colocalization analysis of CD169 and VLP<sub>HIV</sub> in these structures showed a Pearson correlation index of 0.85, indicating a high degree of colocalization degree in both (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). All sac-like compartments phenotypes exhibited colocalization with CD169 expression (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>), thus reinforcing the role of CD169 in mediating viral uptake. To further validate the
abundance of these phenotypes, MDDCs from four additional blood donors were incubated with VLP<sub>HIV</sub> for 2h to maximize the visualization of intermediate polarized and internalized phenotypes (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1</bold>
</xref>).</p>
<p>In conclusion, these data suggest that the actin cytoskeleton plays a role in the early stages of polarization of VLP<sub>HIV</sub>, making it crucial to preserve the structural integrity of sac-like compartments in the final phase. The data also indicates that rearrangement of cortical actin accompanies internalization of HIV at early stages of sac-like compartment formation, suggesting the involvement of a MEND-like mechanism.</p>
</sec>
<sec id="s3_3">
<title>Plasma membrane cholesterol cotraffics with viral particles and accumulates within the sac-like compartment</title>
<p>We subsequently used live confocal microscopy with a fluorescent cholesterol analogue probe to investigate whether the MEND pathway accompanied by cholesterol coalescence could contribute to sac-like compartment formation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Remarkably, the fluorescent signal of the cholesterol analogue increased notably in cell membrane regions containing VLP<sub>HIV</sub>, exhibiting both polarized and internalized distribution phenotypes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). We quantified the fluorescence intensity of this cholesterol probe in membrane regions where viral particles accumulated before sac-like compartment formation and compared it to the average fluorescence intensity of the cellular membrane. Our analysis focused solely on cells displaying the polarization phenotype, as sac-like compartment formation involves membrane folding that enhances the cholesterol fluorescence signal (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). We observed that the cholesterol fluorescence intensity at regions where sac-like compartments were forming was twice as high as in the rest of the membrane. This trend persisted over time, confirming the redistribution and coalescence of cholesterol, with accumulation of VLP<sub>HIV</sub> in the cellular membrane (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Video S3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Cholesterol cotraffics during VLP<sub>HIV</sub> polarization and accumulates within sac-like compartment. MDDCs from three donors were incubated with fluorescently labelled cholesterol or phospholipid DPPE probes (magenta channel), pulsed for 1&#xa0;h with VLP<sub>HIV</sub> (green channel), and analyzed using live cell confocal microscopy. <bold>(A)</bold> Representative images of three different fields showing MDDCs incubated with the cholesterol probe during sac-like compartment formation. <bold>(B)</bold> Quantification of cholesterol fluorescence intensity in membrane areas in 78 MDDCs from three different donors. The relative fluorescence units (RFU) ratio was calculated by dividing fluorescence intensity at the VLP<sub>HIV</sub> polarization region by the fluorescence of the whole membrane. The horizontal bar indicates the average ratio for each donor. The t test was applied to evaluate statistical significance. The P-value for each donor is shown on the graph. Only significant P-values are shown. <bold>(C)</bold> Dynamics of cholesterol accumulation during polarization of VLP<sub>HIV</sub>, as shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. Images were acquired every 5&#xa0;min for 95&#xa0;min. Representative time points during
viral polarization are shown. (<xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Video S3</bold>
</xref>). <bold>(D)</bold> Representative images of three MDDCs incubated with the phospholipid DPPE probe during sac-like compartment formation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1505840-g003.tif"/>
</fig>
<p>As a control, we simultaneously used a fluorescent dipalmitoyl phosphatidylethanolamine analogue probe (DPPE) to assess the lipid bilayer independently of cholesterol lipid rafts (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). In contrast to the cholesterol analogue, this lipid molecule exhibited a uniform distribution in the cell membrane, with no localized increase in membrane regions where VLP<sub>HIV</sub> accumulated.</p>
<p>These findings demonstrate that cholesterol coalescence in the cell membrane is associated with the accumulation of VLP<sub>HIV</sub> prior to sac-like compartment formation, supporting the notion that MEND mechanisms play a crucial role in sac-like compartment formation in myeloid cells.</p>
</sec>
<sec id="s3_4">
<title>Inhibition of palmitoylation arrests sac-like compartment formation without affecting CD169 expression</title>
<p>In accordance with the current definition of MEND, protein palmitoylation initiates the mechanism that facilitates protein coalescence and activates MEND. To assess the significance of protein palmitoylation in sac-like compartment formation in MDDCs, we used the palmitoylation inhibitor 2-bromopalmitate (2-BP). 2-BP abrogates the internalization of VLP<sub>HIV</sub> into the sac-like compartment, halting them at the polarization stage on the cell membrane (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The potential impact of 2-BP on conventional endocytosis pathways was also investigated by separately pulsing MDDCs with transferrin (Tfn) and cholera toxin subunit &#x3b2; (Ctx&#x3b2;)&#x2013;labelled reporters, which are commonly used cargoes for endocytosis assays. No obvious differences were observed in the cell uptake of Tfn or Ctx&#x3b2; after 2-BP treatment, thus ruling the role of palmitoylation in this endocytosis process (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Interestingly, zoomed-in representative cells revealed that VLP<sub>HIV</sub> failed to complete internalization upon treatment with 2-BP. Additionally, CD169 expression remained unaltered following treatment with 2-BP, indicating that arrest of uptake cannot be attributed to a lack of CD169 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Palmitoylation inhibition arrests VLP<sub>HIV</sub> polarization and sac-like compartment formation. MDDCs from nine donors were treated for 2&#xa0;h with 2-bromopalmitate (2-BP) and pulsed for 4&#xa0;h with VLP<sub>HIV</sub> (green channel). In control assays, treated MDDCs were pulsed with transferrin (Tfn) for 30&#xa0;min or with cholera toxin subunit &#x3b2; (Ctx&#x3b2;) for 1&#xa0;h (green channel). The cell cytoplasm was stained with a fluorescent cell tracer probe (red channel). Fixed cells were stained with anti-CD169 Ab (magenta channel). More than 100 cells from each donor were evaluated for each condition. <bold>(A)</bold> Comparative confocal microscopy images of MDDCs pulsed with VLP<sub>HIV</sub>, Tfn, or Ctx&#x3b2; upon treatment with 2-BP. Images show a projection of five to ten Z-slices corresponding to the equatorial area of cargo internalization. <bold>(B)</bold> Representative cell from <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>. <bold>(C)</bold> Quantitative analysis of VLP<sub>HIV</sub> distribution upon treatment with 2-BP according to three different phenotypes: random binding, polarized, and internalized. 4 different experiments were performed using cells from 9 different blood donors. Each dot indicates the percentage of cells for each phenotype for single donors. Violin plots indicate the average percentage of each phenotype for all donors. Median and quartiles are shown in the violin plot. The Wilcoxon test was applied to evaluate statistical significance. The P-value for each phenotype is shown in the graph. Only significant P-values are shown. <bold>(D)</bold> Quantitative analysis of internalization of Tfn and Ctx&#x3b2; in MDDCs upon treatment with 2-BP. Each dot indicates the percentage of cells that have internalized Tfn or Ctx&#x3b2; for single donors. Violin plots indicate the average percentage abundance of each phenotype for all donors. Median and quartiles are represented in the violin plot. The Wilcoxon test was applied to evaluate statistical significance. The P-value is shown in the graph. Only significant P-values are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1505840-g004.tif"/>
</fig>
<p>Quantitative data demonstrated that the proportion of MDDCs arrested at the polarization stage increased from 25% to 60% following treatment with 2-BP compared to untreated MDDCs (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Inversely, treatment with 2-BP drastically reduced sac-like compartment formation (25%) compared to controls (60%), arresting the VLP<sub>HIV</sub> uptake process at the polarization stage (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). MDDCs treated with 2-BP were concurrently pulsed with Tfn- and Ctx&#x3b2;-labelled reporters to evaluate any potential side effects on classical endocytosis pathways (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). We observed that the internalization patterns of transferrin remained unaltered upon treatment and that internalization of Ctx&#x3b2; is minimally affected compared with sac-like compartment formation.</p>
<p>In conclusion, these data suggest that sac-like compartment formation is dependent on protein palmitoylation, which is another essential regulatory mechanism for MEND.</p>
</sec>
<sec id="s3_5">
<title>Inhibition of the PI3K metabolic pathway halts sac-like compartment formation without affecting CD169 expression</title>
<p>To assess the reliance of sac-like compartment formation on (PI(4,5)P<sub>2</sub>) phosphorylation by PI3K, MDDCs from various donors were treated with the PI3K paninhibitor wortmannin prior to the VLP<sub>HIV</sub> pulse. Wortmannin halts sac-like compartment formation at the VLP<sub>HIV</sub> polarization stage in the cell membrane (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). To exclude side effects of wortmannin on conventional endocytosis mechanisms, cell uptake of Tfn or Ctx&#x3b2; was assessed as described above, with no evident differences observed for either after treatment with wortmannin (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). This incomplete VLP<sub>HIV</sub> polarization phenotype is characterized by a semicircular distribution of VLP<sub>HIV</sub>, which do not converge at a single membrane region for internalization. Importantly, treatment with wortmannin does not interfere with either CD169 expression or the attachment of VLP<sub>HIV</sub> (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Inhibition of the PI3K metabolic pathway arrests VLP<sub>HIV</sub> polarization and sac-like compartment formation. MDDCs from seven donors were treated with wortmannin (PI3K inhibitor named Wrtm) for 2&#xa0;h and pulsed for 4&#xa0;h with VLP<sub>HIV</sub> (green channel). In control assays, treated MDDCs were pulsed with Tfn for 30&#xa0;min or with Ctx&#x3b2; for 1&#xa0;h (green channel). The cell cytoplasm was stained with a fluorescent cell tracer probe (red channel). Fixed cells were stained with anti-CD169 Ab (magenta channel). More than 100 cells from each donor were counted for each condition. <bold>(A)</bold> Comparative confocal microscopy images of MDDCs pulsed with VLP<sub>HIV</sub>, Tfn, or Ctx&#x3b2; upon treatment with wortmannin. Images show a projection of five to ten Z-slices corresponding to the equatorial area of cargo internalization. <bold>(B)</bold> Representative cell from <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>. <bold>(C)</bold> Quantitative analysis of VLP<sub>HIV</sub> distribution upon treatment with wortmannin according to 3 different phenotypes: random binding, polarized, and internalized. Each dot indicates the percentage of cells for each phenotype for single donors. Violin plots indicate the average percentage of each phenotype for all donors. Median and quartiles are represented in the violin plot. The Wilcoxon test was applied to evaluate statistical significance. Only significant P-values are shown. <bold>(D)</bold> Quantitative analysis of internalization of Tfn and Ctx&#x3b2; in MDDCs from five donors upon treatment with wortmannin. The Wilcoxon test was applied to evaluate statistical significance. Each dot indicates the percentage of cells that have internalized Tfn or Ctx&#x3b2; for single donors. Violin plots indicate the average percentage abundance of each phenotype for all donors. Median and quartiles are shown in the violin plot. Only significant p-values are shown in the graph. Only significant P-values are shown. <bold>(E)</bold> Quantitative analysis of VLP<sub>HIV</sub> distribution in MDDCs from four donors upon treatment with the macropinocytosis inhibitor EIPA, as evaluated in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>. Each dot indicates the percentage of cells for each phenotype for single donors. Violin plots indicate the average percentage of each phenotype for all donors. Median and quartiles are shown in the violin plot. Only significant P-values are shown. <bold>(F)</bold> Comparative confocal microscopy images of MDDCs pulsed with VLP<sub>HIV</sub> upon treatment with EIPA. Images show a projection of five to ten Z-slices corresponding to the equatorial area of cargo internalization.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1505840-g005.tif"/>
</fig>
<p>Quantitatively, the proportion of cells arrested at the polarization stage after treatment with wortmannin increased from 30% to 50% (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). Moreover, the percentage of MDDCs with internalized VLP<sub>HIV</sub> forming sac-like compartments decreased from over 60% to 40%, halting the VLP<sub>HIV</sub> uptake process at the polarization stage. As a control, we evaluated internalization of Tfn and Ctx&#x3b2;, which was comparable between wortmannin-treated and untreated MDCCs, indicating that wortmannin does not impair conventional endocytosis pathways in this cellular model (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>).</p>
<p>As PI3K metabolism also plays an important role in macropinocytosis, we used the specific macropinocytosis inhibitor 5-(N-ethyl-N-isopropyl) amiloride (EIPA) to evaluate whether the effect observed by wortmannin could be explained by inhibition of macropinocytosis (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5E, F</bold>
</xref>). EIPA functions by inhibiting Na<sup>+</sup>/H<sup>+</sup> exchangers, thereby preventing the activation of intracellular macropinocytosis regulators. Pretreatment with EIPA did not show any significant effect on sac-like compartment formation, confirming that macropinocytosis is not involved in sac-like compartment formation.</p>
<p>Collectively, these findings suggest that when PI3K metabolism is inhibited, internalization of virus in MDDCs is diminished at the polarization stage. This inhibition of PI3K has been reported to be an additional regulatory mechanism of MEND.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Understanding the mechanism underlying internalization of the enveloped virus into myeloid cells plays a critical role in the development of new therapeutical strategies to halt viral dissemination throughout the body. Previous studies employing endocytosis inhibitor treatments have concluded that this route of entry for HIV-1 is clathrin-independent and cholesterol-dependent (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B24">24</xref>), while the involvement of macropinocytosis required further investigation (<xref ref-type="bibr" rid="B14">14</xref>). Since the actin cytoskeleton is dispensable for migration and internalization of viral particles into the sac-like compartment in myeloid cells (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B34">34</xref>) and macropinocytosis relies on actin fibers to mediate membrane folding (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>), we propose that macropinocytosis is not the primary driver mechanism during sac-like compartment formation.</p>
<p>CD169 plays a significant role as an attachment receptor during entry of HIV-1 into activated myeloid cells, because its interaction prompts internalization of viral particles into the sac-like compartment, enhancing subsequent viral trans-infection to target cells (<xref ref-type="bibr" rid="B6">6</xref>). This phenomenon has been further demonstrated using blocking antibodies targeting CD169, which prevent viral uptake, and by the use of point mutants in the ganglioside-binding domain of this cellular receptor (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>). Although there is limited knowledge about which interactors of CD169 might participate in a specific endocytosis mechanism, this study provides novel insights into the CD169-mediated uptake of HIV-1 by myeloid cells and, potentially, of other highly pathogenic enveloped viruses, providing us with new therapeutic targets to halt their dissemination throughout the body.</p>
<p>To facilitate the characterization of this process <italic>in vitro</italic>, we used an MDDC system derived from CD14<sup>+</sup> monocytes isolated from peripheral blood. This system has been validated as an appropriated DC model for studying the role of myeloid cells in HIV-1 <italic>trans</italic>-infection from sac-like compartments upon binding to CD169 (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B13">13</xref>). <italic>Ex vivo</italic> studies have demonstrated that cervical HLA-DR<sup>+</sup> CD14<sup>+</sup> CD11c<sup>+</sup> DCs and tonsillar CD11c<sup>+</sup> BDCA1<sup>+</sup> DCs can capture and <italic>trans</italic>-infect HIV-1 via CD169. Moreover, sac-like compartments have been observed <italic>in vivo</italic> in cervical tissue from infected patients (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Recent studies have shown that MDMs and MDDCs from dermal tissue cultured <italic>ex vivo</italic> express CD169, which partially mediates HIV-1 capture (<xref ref-type="bibr" rid="B16">16</xref>). A recent study evaluating primary human DC subpopulations showed that only a subset constitutively expressing CD169 is susceptible to HIV-1 infection in a CD169&#x2013;dependent manner, thus highlighting the role of this attachment receptor in viral uptake (<xref ref-type="bibr" rid="B38">38</xref>). Other studies have assessed HIV-1 <italic>trans</italic>-infection into CD4<sup>+</sup> T cells in alternative cellular models with limited CD169 expression, indicating that other host factors may be relevant during the process (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Thus, despite their limitations, <italic>in vitro</italic> differentiated MDDCs can serve as a robust model for studying sac-like compartment biogenesis, with the potential to transfer this knowledge to other experimental models of dendritic cells that more closely resemble bona fide DCs (<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>Endocytosis pathways, which typically generate transport intermediates with varying sizes and morphologies, include membrane protrusions that elongate to envelop cargo during phagocytosis (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B42">42</xref>). In our study, we investigated VLP<sub>HIV</sub> uptake in MDDCs using live-cell confocal microscopy to quantitatively describe sac-like compartment dimensions. Our 3D reconstruction data clearly demonstrate that VLP<sub>HIV</sub> migrate to a single pole prior to sac-like compartment formation. Following polarization, VLP<sub>HIV</sub> internalized into a single compartment, with no evidence of smaller endosomal structures coalescing after internalization, as typically observed in the endosome recycling pathway, suggesting that a substantial amount of cell membrane rapidly folds back into the cell. Massive membrane folding is a characteristic compatible with MEND, as more than 50% of the plasma membrane can be internalized in experimental models<sup>25.</sup> In this regard, previous studies have reported that the sac-like compartment maintains continuity with the cell membrane (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B14">14</xref>), implying substantial folding of the cell membrane into cell cytoplasm. We also characterized the morphology and dimensions of the unified sac-like compartment and found that, interestingly, their average dimensions exceeded those typically observed in endosomes generated through conventional endocytosis pathways (<xref ref-type="bibr" rid="B43">43</xref>). Although MEND has been reported to produce vesicles smaller than 250 nm, in contrast to our results, other cell models have shown palmitoylation-dependent endocytosis processes that generate vesicles ranging from 2 &#x3bc;m to 5 &#x3bc;m, suggesting that MEND could produce vesicles of greater sizes (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B43">43</xref>). In our case, we propose that VLP<sub>HIV</sub> utilize MEND mechanisms to form the sac-like compartment instead of triggering a canonical endocytosis process, as sac-like compartment do not incorporate into the endosome pathway and maintain viral particles inside for several hours (<xref ref-type="bibr" rid="B1">1</xref>). The fact that the sac-like compartment is surrounded by an actin cytoskeleton may impede the transport of the VCC to the endolysosomal pathway, thus preserving the infectivity of trapped viruses.</p>
<p>While the actin cytoskeleton is known to participate in various endocytosis mechanisms (<xref ref-type="bibr" rid="B43">43</xref>), its specific role during sac-like compartment formation remains controversial (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B23">23</xref>). The role of actin in sac-like compartment formation was previously reported to be essential, based on the inhibitory effect of latrunculin-A, a compound that disrupts actin cytoskeleton organization (<xref ref-type="bibr" rid="B14">14</xref>). However, this effect could be explained by the dependency of nanoscale CD169 organization on actin fibers, which increases its avidity for ligands (<xref ref-type="bibr" rid="B23">23</xref>). Therefore, actin deregulation may disrupt CD169 nanoscale clusters, hindering VLP<sub>HIV</sub> binding to CD169 and sac-like compartment formation. Thus, actin appears to be essential at the initial stages of sac-like compartment formation. However, after viral binding, the activity of the actin regulators pERM and formin must be abrogated to enable free diffusion of the CD169-virion complex for polarization and internalization (<xref ref-type="bibr" rid="B23">23</xref>). We propose a dual role for actin during sac-like compartment formation, where it is essential for viral binding but dispensable during polarization and sac-like compartment formation. Our findings corroborate this hypothesis, as actin fibers went undetected in some MDDCs with polarized VLP<sub>HIV</sub> and internalized into the sac-like compartment. However, this phenotype did not increase its frequency over time, suggesting that such phenotypes are transient states during the sac-like compartment formation process. Disappearance of actin fibers during sac-like compartment formation correlates with a decrease in the activity of pERM and formin during VLP<sub>HIV</sub> polarization (<xref ref-type="bibr" rid="B23">23</xref>). In contrast, the sac-like compartment increases colocalization with actin over time, indicating that colocalization is the final stage of the sac-like compartment formation process to maintain its structure, in the same way as actin fibers maintain cell shape and organelle structure. Although CD169 is present at every step of the sac-like compartment formation process regardless of the presence of actin, it is still unknown how the binding of viral particles to this receptor triggers actin remodeling and what other potential host factors could bind to actin molecules.</p>
<p>Previous studies utilizing PI3K inhibitors such as LY294002 in MDDCs have shown an arrest in sac-like compartment formation under confocal microscopy, resulting in the random distribution of VLP<sub>HIV</sub> across the membrane (<xref ref-type="bibr" rid="B44">44</xref>). This finding is consistent with our results, which demonstrated the dependency of sac-like compartment formation on PI3K activity. As PI3K also regulates macropinocytosis, we used the specific macropinocytosis inhibitor EIPA before pulsing cells with VLP<sub>HIV</sub> and showed that this endocytosis mechanism is not involved in sac-like compartment formation, in line with previous observations (<xref ref-type="bibr" rid="B14">14</xref>). Anyway, PI3K inhibitors target a central component in cell signaling pathways, making it challenging to delineate the downstream pathway responsible for sac-like compartment internalization and MEND signaling. Nonetheless, this approach provides a novel experimental model for investigating MEND activation under physiological stimuli, as opposed to restrictive experimental conditions implying high concentrations of Ca<sup>2+</sup>, CoA, albumin, or palmitate (<xref ref-type="bibr" rid="B25">25</xref>). Consequently, MDDCs constitute a promising experimental model for advancing comprehension of MEND regulation and triggering mechanisms.</p>
<p>Cholesterol coalescence plays a pivotal role in membrane phase separation processes, serving as a primary driving force of the MEND mechanism. In our findings we present the initial evidence of cholesterol coalescence in MDDCs associated with MEND, as observed in an experimental model using a fluorescent cholesterol probe. While the presence of cholesterol in the cell membrane is crucial for viral <italic>trans</italic>-infection, previous studies assessed its impact on compromised cell viability without evaluating its distribution across the membrane during the sac-like compartment formation process (<xref ref-type="bibr" rid="B1">1</xref>). Our study demonstrated that a cholesterol probe effectively labels the cell membrane in MDDCs without affecting cell viability, enabling real-time visualization of cholesterol coalescence alongside VLP<sub>HIV</sub> within MDDCs.</p>
<p>An association has been observed between palmitoylated proteins and cholesterol raft domains in the cell membrane, leading to their coalescence and initiating membrane phase separation. Thus, protein palmitoylation is a key regulatory mechanism in MEND. Inhibition of palmitoyl-acyl transferase proteins such as DHHC2 and DHHC5 has been shown to decrease MEND activity in various studies (<xref ref-type="bibr" rid="B45">45</xref>&#x2013;<xref ref-type="bibr" rid="B49">49</xref>). In our research, chemical inhibition of these proteins with the inhibitor 2-BP significantly reduces sac-like compartment formation, providing further evidence of the connection between MEND and sac-like compartment formation. Given that palmitic acid residues are saturated fatty acids, they may contribute to the change in lipid density when palmitoylated proteins accumulate at specific sites (<xref ref-type="bibr" rid="B50">50</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>). While CD169 is predicted to have a palmitoylated cysteine position in its cytoplasmatic tail, further investigation is needed to determine whether CD169 is palmitoylated following VLP<sub>HIV</sub> binding, or if alternative host factors interacting with CD169 could undergo palmitoylation.</p>
<p>The sac-like compartment shares characteristics with VCCs in macrophages, which contain <italic>de novo</italic> synthesized virions (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Recent investigations into VCC formation in macrophages suggest the involvement of an alternative endocytosis pathway known as CLIC/GEEC, in HIV-1 uptake (<xref ref-type="bibr" rid="B20">20</xref>). Interestingly, MEND and CLIC/GEEC pathways are similar, with variable dependence on actin remodeling and lipid ordering, suggesting that they may form a continuum of related mechanisms (<xref ref-type="bibr" rid="B25">25</xref>). Therefore, the formation of VCC in macrophages and sac-like compartments in dendritic cells likely involves highly related endocytic mechanisms.</p>
<p>In conclusion, our findings demonstrate extensive plasma membrane invagination and cholesterol coalescence, suggesting lipid-phase separation during internalization of HIV-1 into myeloid cells, which is potentially triggered upon viral binding to CD169. Additionally, the study revealed transient depolarization of cortical actin during sac-like compartment formation, as well as the involvement of regulatory mechanisms such as PIP metabolism and protein palmitoylation. These key processes align with the definition of MEND. The new knowledge we report sheds light on the mechanisms underlying viral uptake into myeloid cells, which is crucial for understanding viral spread throughout the body. These insights open new possibilities for developing novel therapeutic strategies to combat enveloped viruses that use CD169 as an attachment receptor.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The study was approved by the institutional review board for biomedical research of Hospital Germans Trias i Pujol (HUGTiP).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>FL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. JC: Methodology, Resources, Visualization, Writing &#x2013; review &amp; editing. IE: Methodology, Visualization, Writing &#x2013; review &amp; editing. MG: Conceptualization, Supervision, Writing &#x2013; review &amp; editing. CE: Conceptualization, Supervision, Writing &#x2013; review &amp; editing. JM-P: Conceptualization, Data curation, Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing. PR-I: Conceptualization, Data curation, Methodology, Project administration, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors&#x2019; laboratories were supported by funding from the Spanish Ministry of Science and Innovation (grants PID2022-139271OB-I00 and CB21/13/00063, Spain), NIH/NIAID (1UM1AI164561-01 and 1P01AI178376-01, United States of America), Generalitat de Val&#xe8;ncia (grant PROMETEO/2021/036, Spain), and Grifols (Spain).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank prof. Christian Eggeling (Friedrich Schiller University Jena &amp; Leibniz Institute of Photonic Technology, Jena, Germany) for kindly providing us with Cholesterol-PEG(1K)-Abberior STAR RED. We are grateful to the Molecular Imaging Platform at the Molecular Biology Institute of Barcelona for help in the acquisition of fluorescence microscopy images, especially Elena Rebollo (IBMB-CSIC, Barcelona, Spain) for her contribution to establish the imaging methodologies. We thank the Scientific and technical services (IrsiCaixa) for the blood sample processing and PBMCs isolation.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>JM-P has received institutional grants and educational/consultancy fees from AbiVax, AstraZeneca, Gilead Sciences, Grifols, Janssen, Merck Sharp &amp; Dohme, and ViiV Healthcare, all outside the submitted work.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505840/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505840/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Video1.avi" id="SM1" mimetype="video/x-msvideo">
<label>Supplementary Video 1</label>
<caption>
<p>Z-slice confocal live microscopy video to illustrate VLP<sub>HIV</sub> uptake by MDDCs and sac-like compartment formation. Cells were plated onto poly-L-lysine plastic culture dishes, mounted in a microscope chamber at 37&#xb0;C, 5% CO<sub>2</sub>, and imaged at 2-min intervals using confocal fluorescence microscopy immediately after the VLP<sub>HIV</sub> pulse (green channel). Cell volume was determined with a cell tracer fluorescent probe (red channel). The video was rendered using the reslice tool in FIJI.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Video2.avi" id="SM2" mimetype="video/x-msvideo">
<label>Supplementary Video 2</label>
<caption>
<p>3D reconstruction confocal live microscopy video to illustrate VLP<sub>HIV</sub> uptake by MDDCs and sac-like compartment formation. Cells were plated onto poly-L-lysine plastic culture dishes, mounted in a microscope chamber at 37&#xb0;C, 5% CO<sub>2</sub>, and imaged at 2-min intervals using confocal fluorescence microscopy immediately after the VLP<sub>HIV</sub> pulse (green channel). The cell volume was determined with a cell tracer fluorescent probe (red channel). The video was rendered using the 3D reconstruction in FIJI.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Video3.avi" id="SM3" mimetype="video/x-msvideo">
<label>Supplementary Video 3</label>
<caption>
<p>Confocal live microscopy video to illustrate cholesterol coalescence during VLP<sub>HIV</sub> uptake and polarization by MDDCs. Cells incubated with a fluorescent cholesterol probe (purple channel) were plated onto poly-L-lysine plastic culture dishes, mounted in a microscope chamber at 37&#xb0;C, 5% CO<sub>2</sub>, and imaged at 5-min intervals using confocal fluorescence microscopy immediately after the VLP<sub>HIV</sub> pulse (green channel).</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>VLP<sub>HIV</sub> distribution depending on actin colocalization in MDDCs from six donors. Analysis of VLP<sub>HIV</sub> distribution in MDDCs from six donors classified as indicated in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>. Cells were pulsed with VLP<sub>HIV</sub> and fixed at 2h. At least 20 cells were evaluated at each time point. The graph shows percentage  values above 10% for each phenotype.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF2" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo-Useros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>J</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Figueras</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Borr&#xe0;s</surname> <given-names>FE</given-names>
</name>
<name>
<surname>Naranjo-G&#xf3;mez</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission</article-title>. <source>J Virol</source>. (<year>2007</year>) <volume>81</volume>:<page-range>7559&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.02572-06</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Zsolt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cantero-P&#xe9;rez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Benet</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Serra-Peinado</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Dendritic cells from the cervical mucosa capture and transfer HIV-1 via siglec-1</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>1</elocation-id>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00825</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J-H</given-names>
</name>
<name>
<surname>Janas</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Olson</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells</article-title>. <source>J Virol</source>. (<year>2007</year>) <volume>81</volume>:<page-range>8933&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.00878-07</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erikson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wratil</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ambiel</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pahnke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pino</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Mouse siglec-1 mediates trans-infection of surface-bound murine leukemia virus in a sialic acid N-acyl side chain-dependent manner</article-title>. <source>J Biol Chem</source>. (<year>2015</year>) <volume>290</volume>:<page-range>27345&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M115.681338</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo-Useros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lorizate</surname> <given-names>M</given-names>
</name>
<name>
<surname>Contreras</surname> <given-names>FX</given-names>
</name>
<name>
<surname>Rodriguez-Plata</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Glass</surname> <given-names>B</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1</article-title>. <source>PloS Biol</source>. (<year>2012</year>) <volume>10</volume>:<elocation-id>e1001315</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.1001315</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo-Useros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lorizate</surname> <given-names>M</given-names>
</name>
<name>
<surname>Puertas</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Rodriguez-Plata</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Zangger</surname> <given-names>N</given-names>
</name>
<name>
<surname>Erikson</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides</article-title>. <source>PloS Biol</source>. (<year>2012</year>) <volume>10</volume>:<elocation-id>e1001448</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.1001448</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Zsolt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Garc&#xed;a-Gallo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Benet</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry</article-title>. <source>Nat Microbiol</source>. (<year>2019</year>) <volume>4</volume>:<page-range>1558&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0453-2</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Zsolt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mu&#xf1;oz-Basagoiti</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rodon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Elosua-Bayes</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ra&#xef;ch-Regu&#xe9;</surname> <given-names>D</given-names>
</name>
<name>
<surname>Risco</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells</article-title>. <source>Cell Mol Immunol</source>. (<year>2021</year>) <volume>18</volume>:<page-range>2676&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-021-00794-6</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puryear</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ramirez</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Reinhard</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Gummuluru</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2012</year>) <volume>109</volume>:<page-range>7475&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1201104109</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puryear</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Akiyama</surname> <given-names>H</given-names>
</name>
<name>
<surname>Geer</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Ramirez</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Reinhard</surname> <given-names>BM</given-names>
</name>
<etal/>
</person-group>. <article-title>Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on siglec-1/CD169</article-title>. <source>PloS Pathog</source>. (<year>2013</year>) <volume>9</volume>:<elocation-id>e1003291</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003291</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyun</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Reuter</surname> <given-names>MA</given-names>
</name>
<name>
<surname>McDonald</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells</article-title>. <source>PloS Pathog</source>. (<year>2008</year>) <volume>4</volume>:<elocation-id>e1000134</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1000134</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo-Useros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Naranjo-G&#xf3;mez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Archer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hatch</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway</article-title>. <source>Blood</source>. (<year>2009</year>) <volume>113</volume>:<page-range>2732&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2008-05-158642</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Gregorio</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bitton</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hendrickson</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Littman</surname> <given-names>DR</given-names>
</name>
</person-group>. <article-title>DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection</article-title>. <source>Immunity</source>. (<year>2002</year>) <volume>16</volume>:<page-range>135&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1074-7613(02)00259-5</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo-Useros</surname> <given-names>N</given-names>
</name>
<name>
<surname>Esteban</surname> <given-names>O</given-names>
</name>
<name>
<surname>Rodriguez-Plata</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Prado</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells</article-title>. <source>Traffic</source>. (<year>2011</year>) <volume>12</volume>:<page-range>1702&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0854.2011.01281.x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Benet</surname> <given-names>S</given-names>
</name>
<name>
<surname>Erikson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Figueras</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Guerrero</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells</article-title>. <source>Retrovirology</source>. (<year>2015</year>) <volume>12</volume>:<fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12977-015-0160-x</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhodes</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Botting</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Bertram</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Vine</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Rana</surname> <given-names>H</given-names>
</name>
<name>
<surname>Baharlou</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells</article-title>. <source>Nat Commun</source>. (<year>2021</year>) <volume>12</volume>:<fpage>2147</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-021-22375-x</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vine</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Warner van Dijk</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Byrne</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Bertram</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Cunningham</surname> <given-names>AL</given-names>
</name>
<etal/>
</person-group>. <article-title>HIV transmitting mononuclear phagocytes; integrating the old and new</article-title>. <source>Mucosal Immunol</source>. (<year>2022</year>) <volume>15</volume>:<page-range>542&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-022-00492-0</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammonds</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Beeman</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>L</given-names>
</name>
<name>
<surname>Takushi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Francis</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1</article-title>. <source>PloS Pathog</source>. (<year>2017</year>) <volume>13</volume>:<elocation-id>e1006181</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006181</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graziano</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vicenzi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Poli</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Immuno-pharmacological targeting of virus-containing compartments in HIV-1-infected macrophages</article-title>. <source>Trends Microbiol</source>. (<year>2016</year>) <volume>24</volume>:<page-range>558&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2016.02.018</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Candor</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>L</given-names>
</name>
<name>
<surname>Balchand</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hammonds</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Spearman</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The CLIC/GEEC pathway regulates particle endocytosis and formation of the virus-containing compartment (VCC) in HIV-1-infected macrophages</article-title>. <source>bioRxiv</source> (<year>2024</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2024.09.05.611375</pub-id>. Preprint.</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Schelhaas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Helenius</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Virus entry by endocytosis</article-title>. <source>Annu Rev Biochem</source>. (<year>2010</year>) <volume>79</volume>:<page-range>803&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biochem-060208-104626</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crocker</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Paulson</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Varki</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Siglecs and their roles in the immune system</article-title>. <source>Nat Rev Immunol</source>. (<year>2007</year>) <volume>7</volume>:<page-range>255&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2056</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guti&#xe9;rrez-Mart&#xed;nez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Garrab&#xe9;</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Mateos</surname> <given-names>N</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Nieto-Garai</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Lorizate</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells</article-title>. <source>Elife</source>. (<year>2023</year>) <volume>12</volume>:<elocation-id>e78836</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.78836.sa2</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gummuluru</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rogel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stamatatos</surname> <given-names>L</given-names>
</name>
<name>
<surname>Emerman</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway</article-title>. <source>J Virol</source>. (<year>2003</year>) <volume>77</volume>:<page-range>12865&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.77.23.12865-12874.2003</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilgemann</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deisl</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>On the existence of endocytosis driven by membrane phase separations</article-title>. <source>Biochim Biophys Acta Biomembr</source>. (<year>2020</year>) <volume>1862</volume>:<fpage>183007</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamem.2019.06.006</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renard</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Boucrot</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Unconventional endocytic mechanisms</article-title>. <source>Curr Opin Cell Biol</source>. (<year>2021</year>) <volume>71</volume>:<page-range>120&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ceb.2021.03.001</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilgmann</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Linder</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Jennings</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Massive endocytosis triggered by surface membrane palmitoylation under mitochondrial control in BHK fibroblasts</article-title>. <source>Elife</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.01293.012</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Hofmann</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Frazier</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hilgemann</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Massive palmitoylation-dependent endocytosis during reoxygenation of anoxic cardiac muscle</article-title>. <source>Elife</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.01295</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reilly</surname> <given-names>L</given-names>
</name>
<name>
<surname>Howie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wypijewski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ashford</surname> <given-names>MLJ</given-names>
</name>
<name>
<surname>Hilgemann</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Fuller</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling</article-title>. <source>FASEB J</source>. (<year>2015</year>) <volume>29</volume>:<page-range>4532&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.15-276493</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lariccia</surname> <given-names>V</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Magi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Yaradanakul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Llaguno</surname> <given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Massive calcium-activated endocytosis without involvement of classical endocytic proteins</article-title>. <source>J Gen Physiol</source>. (<year>2011</year>) <volume>137</volume>:<page-range>111&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1085/jgp.201010468</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araki</surname> <given-names>N</given-names>
</name>
<name>
<surname>Egami</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hatae</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Phosphoinositide metabolism during membrane ruffling and macropinosome formation in EGF-stimulated A431 cells</article-title>. <source>Exp Cell Res</source>. (<year>2007</year>) <volume>313</volume>:<page-range>1496&#x2013;507</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2007.02.012</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimmer</surname> <given-names>S</given-names>
</name>
<name>
<surname>van Deurs</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sandvig</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Membrane ruffling and macropinocytosis in A431 cells require cholesterol</article-title>. <source>J Cell Sci</source>. (<year>2002</year>) <volume>115</volume>:<page-range>2953&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.115.14.2953</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Yaradanakul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lariccia</surname> <given-names>V</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Hilgemann</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Dual control of cardiac Na+-Ca2+ exchange by PIP2: Analysis of the surface membrane fraction by extracellular cysteine PEGylation</article-title>. <source>J Physiol</source>. (<year>2007</year>) <volume>582</volume>:<page-range>1011&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/jphysiol.2007.132720</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname> <given-names>M</given-names>
</name>
<name>
<surname>Llaguno</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Lariccia</surname> <given-names>V</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Yaradanakul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hilgemann</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Massive endocytosis driven by lipidic forces originating in the outer plasmalemmal monolayer: A new approach to membrane recycling and lipid domains</article-title>. <source>J Gen Physiol</source>. (<year>2011</year>) <volume>137</volume>:<page-range>137&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1085/jgp.201010469</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honigmann</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mueller</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ta</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schoenle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sezgin</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hell</surname> <given-names>SW</given-names>
</name>
<etal/>
</person-group>. <article-title>Scanning STED-FcS reveals spatiotemporal heterogeneity of lipid interaction in the plasma membrane of living cells</article-title>. <source>Nat Commun</source>. (<year>2014</year>) <volume>5</volume>:<fpage>5412</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms6412</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinkwart</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lukoseviciute</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sauka-Spengler</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lyman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Eggeling</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Nanoscale dynamics of cholesterol in the cell membrane</article-title>. <source>J Biol Chem</source>. (<year>2019</year>) <volume>294</volume>:<page-range>12599&#x2013;609</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.RA119.009683</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resa-Infante</surname> <given-names>P</given-names>
</name>
<name>
<surname>Erkizia</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mu&#xf1;iz-Trabudua</surname> <given-names>X</given-names>
</name>
<name>
<surname>Linty</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bentlage</surname> <given-names>AEH</given-names>
</name>
<name>
<surname>Perez-Zsolt</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy</article-title>. <source>Biomedicine Pharmacotherapy</source>. (<year>2024</year>) <volume>175</volume>:<fpage>116726</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2024.116726</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruffin</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gea-Mallorqu&#xed;</surname> <given-names>E</given-names>
</name>
<name>
<surname>Brouiller</surname> <given-names>F</given-names>
</name>
<name>
<surname>Jouve</surname> <given-names>M</given-names>
</name>
<name>
<surname>Silvin</surname> <given-names>A</given-names>
</name>
<name>
<surname>See</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursors</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2019</year>) <volume>116</volume>:<page-range>21685&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1911007116</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ramirez</surname> <given-names>NGP</given-names>
</name>
<name>
<surname>Gudheti</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Gummuluru</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies</article-title>. <source>PloS Pathog</source>. (<year>2015</year>) <volume>11</volume>:<fpage>1</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1004751</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertram</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Botting</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Baharlou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Rana</surname> <given-names>H</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of HIV transmitting CD11c+ human epidermal dendritic cells</article-title>. <source>Nat Commun</source>. (<year>2019</year>) <volume>10</volume>:<fpage>2759</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-10697-w</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Arnold-Schrauf</surname> <given-names>C</given-names>
</name>
<name>
<surname>Abbas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Couespel</surname> <given-names>N</given-names>
</name>
<name>
<surname>Savoret</surname> <given-names>J</given-names>
</name>
<name>
<surname>Imperatore</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Large-scale human dendritic cell differentiation revealing notch-dependent lineage bifurcation and heterogeneity</article-title>. <source>Cell Rep</source>. (<year>2018</year>) <volume>24</volume>:<fpage>1902</fpage>&#x2013;<lpage>1915.e6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.033</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niedergang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Grinstein</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>How to build a phagosome: new concepts for an old process</article-title>. <source>Curr Opin Cell Biol</source>. (<year>2018</year>) <volume>50</volume>:<fpage>57</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ceb.2018.01.009</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rennick</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>APR</given-names>
</name>
<name>
<surname>Parton</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics</article-title>. <source>Nat Nanotechnol</source>. (<year>2021</year>) <volume>16</volume>:<page-range>266&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41565-021-00858-8</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayliss</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wheeldon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Caucheteux</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Niessen</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Piguet</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Identification of host trafficking genes required for HIV-1 virological synapse formation in dendritic cells</article-title>. <source>J Virol</source>. (<year>2020</year>) <volume>94</volume>:<fpage>1</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.01597-19</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badawy</surname> <given-names>SMM</given-names>
</name>
<name>
<surname>Okada</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kajimoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ijuin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>SI</given-names>
</name>
</person-group>. <article-title>DHHC5-mediated palmitoylation of S1P receptor subtype 1 determines G-protein coupling</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-16457-4</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brigidi</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Santyr</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shimell</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jovellar</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bamji</surname> <given-names>SX</given-names>
</name>
</person-group>. <article-title>Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5</article-title>. <source>Nat Commun</source>. (<year>2015</year>) <volume>6</volume>:<fpage>8200</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms9200</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greaves</surname> <given-names>J</given-names>
</name>
<name>
<surname>Carmichael</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Chamberlain</surname> <given-names>LH</given-names>
</name>
</person-group>. <article-title>The palmitoyl transferase DHHC2 targets a dynamic membrane cycling pathway: Regulation by a C-terminal domain</article-title>. <source>Mol Biol Cell</source>. (<year>2011</year>) <volume>22</volume>:<page-range>1887&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1091/mbc.e10-11-0924</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Reilly</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fraser</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>JMV</given-names>
</name>
<name>
<surname>Wypijewski</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Ashford</surname> <given-names>MLJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Substrate recognition by the cell surface palmitoyl transferase DHHC5</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2014</year>) <volume>111</volume>:<page-range>17534&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1413627111</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolfrey</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Sanderson</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Dell&#x2019;Acqua</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>The palmitoyl acyltransferase DHHC2 regulates recycling endosome exocytosis and synaptic potentiation through palmitoylation of AKAP79/150</article-title>. <source>J Neurosci</source>. (<year>2015</year>) <volume>35</volume>:<page-range>442&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2243-14.2015</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Shipston</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>The physiology of protein s-acylation</article-title>. <source>Physiol Rev</source>. (<year>2015</year>) <volume>95</volume>:<page-range>341&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00032.2014</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwiatkowska</surname> <given-names>K</given-names>
</name>
<name>
<surname>Matveichuk</surname> <given-names>OV</given-names>
</name>
<name>
<surname>Fronk</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ciesielska</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Flotillins: At the intersection of protein S-palmitoylation and lipid-mediated signaling</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<fpage>1</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21072283</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobocinska</surname> <given-names>J</given-names>
</name>
<name>
<surname>Roszczenko-Jasinska</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ciesielska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kwiatkowska</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Protein palmitoylation and its role in bacterial and viral infections</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>8</volume>:<elocation-id>1</elocation-id>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.02003</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaballa</surname> <given-names>ME</given-names>
</name>
<name>
<surname>van der Goot</surname> <given-names>FG</given-names>
</name>
</person-group>. <article-title>The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics</article-title>. <source>Crit Rev Biochem Mol Biol</source>. (<year>2018</year>) <volume>53</volume>:<page-range>420&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10409238.2018.1488804</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>